Director sold
Stock since the trade -3.3% · S&P 500 -0.8% · to Oct 1Traded 31 days after resultsStock within 2% of its 52-week low
Loading…
Idexx Laboratories
IDXX · NASDAQ · Health Care Equipment
IDXX · NASDAQ · Health Care Equipment
Health Care Equipment company based in Westbrook, Maine.
Last close, Oct 1, 2026
$517.75
Adjusted for splits and dividends
Last 12 months
-16.5%
S&P 500 +14.3% over the same dates
Market value
$40.8B
Last close × shares outstanding
Bets against the stock: 1.92M shares sold short (2.4% of shares outstanding), -8.4% vs the previous count, 3.8 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
1 sale
$1.17M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$4.3B
+10.4% vs the year before
Net income, fiscal 2025
$1.06B
As reported in the annual filing
Shares outstanding
78.8M
As of Jul 31, 2026
In fiscal 2025 the company spent $1.22B buying back its own shares. Cash actually paid, from its cash-flow statement.
Stock since the trade -3.3% · S&P 500 -0.8% · to Oct 1Traded 31 days after resultsStock within 2% of its 52-week low
A board member of Idexx Laboratories sold $1.17M of Idexx Laboratories shares. Nobody planned it ahead of time.
Director plans to sell ~$1.17M of Idexx Laboratories
Planned, from payFrom a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Stock since the trade -18.5% · S&P 500 +12.3% · to Oct 1Traded 29 days after resultsStock down 11% in the previous month
20K → 18K shares held−9% of their stake
Idexx Laboratories's Executive Vice President sold $1.12M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
95K → 91K shares held−4% of their stake
The boss of Idexx Laboratories sold $2.41M of Idexx Laboratories shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Short sale volume: 39.0% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 52.1%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
Last 12 months, adjusted daily closes
Adjusted close went from $620.11 on Oct 1, 2025 to $517.75 on Oct 1, 2026 (-16.5%). Disclosed trades in the last 12 months: 0 insider purchases, 36 insider sales, 0 Congress purchases, 2 Congress sales.
8 certified in FY2026 Q3, vs 9 a year earlier. 8 positions in total, median offered wage $143K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.